Sign In

Augusto Carlos Carlos Pellarini Seguí

CFO | M&A | Angel Investor | Venture Capital | Early Stage Startup Advisor | Enterprise Valuation Expert | Growth Strategy

Augusto Carlos P. is the Head of Finance and Administration (Advisor) at SAMU First Response. He has over 25 years of experience in corporate finance, strategy, valuations, and mergers and acquisitions (M&A). He studied at IESE Business School, which is affiliated with the University of Navarra. His extensive background suggests a strong expertise in financial management and strategic planning within organizations.

Highlights

Jul 31 · linkedin

🚀 Sangamo Therapeutics, Inc. has exciting news! The Q2 2024 financial results will be released on August 6. I hope to get a great updated into the innovative work in #genomicmedicine. It goes beyond numbers, symbolizing a transformative potential in the field.

The commitment of Sangamo Therapeutics, Inc. in addressing critical #neurologicaldiseases through pioneering #geneditingtechnology is truly inspiring. Their use of #zincfinger #epigenetic #regulators and advancements in the #capsid discovery platform showcase their dedication to pushing boundaries in treatment options. #ZFP #ZiFi #genediting #gentherapy Eagerly awaiting updates on strategic direction and the promising pipeline of programs led by Sandy Macrae, MRCP PhD and his team. The hope for insights on #partnering #deals adds to the excitement!

For all intrigued by the future of #geneditingmedicine and the vast potential of #genomictherapies, mark your calendars for this essential event. 🌟 Here is the link https://lnkd.in/eCkt9BUX

Jul 27 · linkedin

Who's been following the positive news from Pfizer on July 24, 2024, regarding the Phase III data on hemophilia A? Sangamo Therapeutics, Inc. has seen a remarkable uptake of its stock $SGMO this past week, with the share price up by +115.84% (+0.46 )! The total volume of shares traded last week reached 431,779,193 according to Sangamo Therapeutics, Inc.'s webpage. Will we see more of this trend? Many thanks to Alex Philippidis for the insightful summary on Sangamo in his new edition of #Stockwatch post from July 26, 2024: https://lnkd.in/eryxtEx6. Could it be that the #GeneTherapy community is finally deciphering the developments in #CRISPR and #ZincFinger? #GenEditing

Related Questions

What are some of the key projects Augusto Carlos P. has worked on at SAMU First Response?
How did Augusto Carlos P. transition from corporate finance to his current role at SAMU First Response?
What is Augusto Carlos P.'s educational background and how has it influenced his career?
Can you provide examples of Augusto Carlos P.'s achievements in corporate finance and strategy?
What are the main responsibilities of the Head of Finance and Administration at SAMU First Response?
Augusto Carlos Carlos Pellarini Seguí
Augusto Carlos Carlos Pellarini Seguí, photo 1
Augusto Carlos Carlos Pellarini Seguí, photo 2
Add to my network

Location

Washington, District of Columbia, United States